Table 1 Demographic and clinical characteristics of the study population
Characteristics | Characteristics of the sample Count (%)/Mean(± SD) N = 3165 | Prevalence within subgroup Count (%)/Mean(± SD) | P value | |
|---|---|---|---|---|
No Anticoagulation N = 2138 (67.6%) | Anticoagulation N = 1027(32.4%) | |||
Age(years), Mean | 85.3(4.3) | 85.7(4.5) | 84.3(3.5) | < 0.001 |
Age(years), N(%) | < 0.001 | |||
80–84 | 1588(50.2) | 977(45.7) | 611(59.5) | |
85–89 | 1083(34.2) | 761(35.6) | 322(31.4) | |
90 + | 494(15.6) | 400(18.7) | 94(9.2) | |
Sex, N(%) | < 0.001 | |||
Male | 1824(57.6) | 1301(60.9) | 523(50.9) | |
Female | 1341(42.4) | 837(39.1) | 504(49.1) | |
CHA2DS2-VASC Score*, Mean | 4.1(1.3) | 4.1(1.3) | 4.2(1.3) | 0.006 |
CHA2DS2-VASC*, Median | 4(3–5) | 4(3–5) | 4(3–5) | 0.007 |
HAS- BLED Score*, Mean | 4(1.2) | 4.1(1.3) | 3.9(1.1) | < 0.001 |
HAS- BLED Score*, Median | 4(3–5) | 4(3–5) | 4(3–5) | < 0.001 |
HAS- BLED Score, N(%) | < 0.001 | |||
HAS- BLED Score < 3 | 308(9.7) | 205(9.6) | 103(10) | |
3 < = HAS- BLED Score < = 4 | 1771(56) | 1148(53.7) | 623(60.7) | |
HAS- BLED Score > = 5 | 1086(34.3) | 785(36.7) | 301(29.3) | |
Clinical department, N(%) | < 0.001 | |||
Cardiology | 786(24.8) | 383(17.9) | 403(39.2) | |
Geriatrics | 1129(35.7) | 834(39) | 295(28.7) | |
Neurology | 311(9.8) | 169(7.9) | 142(13.8) | |
Others | 939(29.7) | 752(35.2) | 187(18.2) | |
Use of antiplatelets, Yes, N(%) | 1392(44) | 1028(48.1) | 364(35.4) | < 0.001 |
ASA, Yes, N(%) | 739(23.3) | 504(23.6) | 235(22.9) | 0.7 |
Clopidogrel, Yes, N(%) | 1014(32) | 767(35.9) | 247(24.1) | < 0.001 |
CCI*, Mean | 1.9(2) | 2.1(2.1) | 1.6(1.7) | < 0.001 |
CCI*, Median | 1(1–3) | 2(1–3) | 1(0–2) | < 0.001 |
CCI | < 0.001 | |||
CCI: 0 | 687(21.7) | 424(19.8) | 263(25.6) | |
CCI: 1–2 | 1663(52.5) | 1096(51.3) | 567(55.2) | |
CCI: 3 + | 815(25.8) | 618(28.9) | 197(19.2) | |
Hypertension, Yes, N(%) | 2168(68.5) | 1460(68.3) | 708(68.9) | 0.743 |
Diabetes, Yes, N(%) | 859(27.1) | 570(26.7) | 289(28.1) | 0.404 |
Stroke, Yes, N(%) | 1065(33.6) | 706(33) | 359(35) | 0.299 |
CHD, Yes, N(%) | 1393(44) | 934(43.7) | 459(44.7) | 0.62 |
Thromboembolic disease, Yes, N(%) | 876(27.7) | 576(26.9) | 300(29.2) | 0.196 |
Dementia, Yes, N(%) | 283(8.9) | 229(10.7) | 54(5.3) | < 0.001 |
Year of hospitalization, N(%) | < 0.001 | |||
2016–2017 | 722(22.8) | 571(26.7) | 151(14.7) | |
2017–2018 | 826(26.1) | 589(27.5) | 237(23.1) | |
2018–2019 | 851(26.9) | 548(25.6) | 303(29.5) | |
2019–2020 | 766(24.2) | 430(20.1) | 336(32.7) | |